Corrigendum.
- Published in:
- 2023
- Publication type:
- Correction Notice
Works matching IS 18817815 AND DT 2023 AND VI 17 AND IP 6
Results: 11
1
2
Corrigendum.
- Published in:
- 2023
- Publication type:
- Correction Notice
3
Development of a novel cholesterol tag-based system for transmembrane transport of protein drugs.
- Published in:
- BioScience Trends, 2023, v. 17, n. 6, p. 503, doi. 10.5582/bst.2023.01285
- By:
- Publication type:
- Article
4
Immunity debt: Hospitals need to be prepared in advance for multiple respiratory diseases that tend to co-occur.
- Published in:
- BioScience Trends, 2023, v. 17, n. 6, p. 499, doi. 10.5582/bst.2023.01303
- By:
- Publication type:
- Article
5
Pal power: Demonstration of the functional association of the Helicobacter pylori flagellar motor with peptidoglycan-associated lipoprotein (Pal) and its preliminary crystallographic analysis.
- Published in:
- BioScience Trends, 2023, v. 17, n. 6, p. 491, doi. 10.5582/bst.2023.01278
- By:
- Publication type:
- Article
6
Feasibility of novel intraoperative navigation for anatomical liver resection using real-time virtual sonography combined with indocyanine green fluorescent imaging technology.
- Published in:
- BioScience Trends, 2023, v. 17, n. 6, p. 484, doi. 10.5582/bst.2023.01265
- By:
- Publication type:
- Article
7
Risk factors for postoperative recurrence of pT2-3N0M0 esophageal squamous cell carcinoma and patterns of its recurrence.
- Published in:
- BioScience Trends, 2023, v. 17, n. 6, p. 475, doi. 10.5582/bst.2023.01294
- By:
- Publication type:
- Article
8
The effect of the female genital tract and gut microbiome on reproductive dysfunction.
- Published in:
- BioScience Trends, 2023, v. 17, n. 6, p. 458, doi. 10.5582/bst.2023.01133
- By:
- Publication type:
- Article
9
An update on diagnosis and treatment of hepatoblastoma.
- Published in:
- BioScience Trends, 2023, v. 17, n. 6, p. 445, doi. 10.5582/bst.2023.01311
- By:
- Publication type:
- Article
10
The immune response of hepatocellular carcinoma after locoregional and systemic therapies: The available combination option for immunotherapy.
- Published in:
- BioScience Trends, 2023, v. 17, n. 6, p. 427, doi. 10.5582/bst.2023.01275
- By:
- Publication type:
- Article
11
Conversion therapy for initially unresectable hepatocellular carcinoma: Current status and prospects.
- Published in:
- BioScience Trends, 2023, v. 17, n. 6, p. 415, doi. 10.5582/bst.2023.01322
- By:
- Publication type:
- Article